Results
Thomas De Doncker
Read more
Mieke De Volder
Read more
VUB TechTransfer
Read more
Legal Team
Read more
Ine De Bock
Read more
Goedele Nuyttens
Read more
Brussels projects
Read more
Extension to proven TriMix® adjuvant technology intended to boost dendritic cell activation
eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, announces the expansion of its strategic collaboration with the VUB with the signing of an exclusive license for TetraMix® , a new generation of th...
Read more
SUN
Read more